Open AccessImproved efficacy using rituximab and brief duration, high intensity chemotherapy with filgrastim support for Burkitt or aggressive lymphomas: cancer and Leukemia Group B study 10 002
Author(s) -
David A. Rizzieri,
Jeffrey L. Johnson,
John C. Byrd,
Gerard Lozanski,
Kristie A. Blum,
Bayard L. Powell,
Thomas C. Shea,
Sreenivasa Nattam,
Eva Hoke,
Bruce D. Cheson,
Richard A. Larson
Publication year - 2014
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/h8a4-x656
Subject(s) - medicine , oncology , rituximab , lymphoma , filgrastim , leukemia , chemotherapy , granulocyte colony stimulating factor